Title : Rosuvastatin decreases serum inflammatory markers and slows atherosclerosis progression rate in treated HIV-infected patients with metabolic syndrome.

Pub. Date : 2021 Feb

PMID : 32955957






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 After 12 months, rosuvastatin produced a significant decrease in mean serum levels of hsCRP (-0.28 mg/dL; p = .037), IL-6 (-2.1 pg/mL; p = .018) and TNF-alpha (-6.3 pg/mL; p = .004) in patients with MetS. Rosuvastatin Calcium interleukin 6 Homo sapiens